Physician

Alan E Skolnick, M.D.

According to 2025 Medicare claims, Alan Skolnick, M.D. (NPI: 1548287121) practices cardiology in the Anchorage, AK market, with the plurality of this provider's patient population coming from Anchorage, AK. This provider's primary affiliated billing organization is ALASKA HEART INSTITUTE (NPI: 1992744114; TIN: 92-0165692) and primary practice location at 99508-4674. Skolnick is affiliated with the CHSPSC ACO 8, LLC (ACO ID: A3715) and Envoy Integrated Health ACO, LLC (ACO ID: A5392), participating under the MSSP model.

Skolnick's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,104 traditional Medicare patients, billed 14,215 HCPCS/CPT codes, and received $469,324 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,687 prescription claims across 429 beneficiaries totaling $953,418 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 12 claims. Open Payments data shows 1 records totaling $42. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $161,903 to $953,418. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $4,144 to $2,481.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,899	11,506	$469,969
2016	2,009	13,295	$583,004
2017	2,011	20,725	$465,805
2018	2,023	32,263	$521,483
2019	2,149	25,238	$581,717
2020	1,872	8,004	$455,593
2021	1,861	8,027	$528,704
2022	1,749	8,756	$460,957
2023	2,091	12,928	$486,913
2024	2,104	14,215	$469,324

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	192	2,418	$161,903
2016	217	2,142	$173,404
2017	209	2,601	$217,435
2018	207	2,203	$205,763
2019	348	3,827	$498,673
2020	392	4,279	$646,411
2021	406	4,587	$699,350
2022	417	4,508	$805,240
2023	410	4,384	$861,314
2024	429	4,687	$953,418

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	34	$3,343
2016	N/R	N/R	N/R
2017	N/R	11	$276
2018	N/R	N/R	N/R
2019	N/R	12	$382
2020	N/R	11	$355
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	12	$595
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	170	215	$119
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	528	536	$114
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	286	320	$75
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	135	137	$66
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	857	1,010	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	278	21,650	$410,182
Entresto	Sacubitril/Valsartan	83	6,074	$115,177
Xarelto	Rivaroxaban	69	5,280	$96,490
Repatha Sureclick	Evolocumab	89	4,478	$84,375
Jardiance	Empagliflozin	36	3,157	$59,620

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$42	ATRICURE, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alan E. Skolnick, M.D.?

Tedicare shows public-source Medicare data for Alan E. Skolnick, M.D. (NPI 1548287121), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan E. Skolnick, M.D. have ACO affiliation data?

Alan E. Skolnick, M.D. is shown with ACO affiliation data for CHSPSC ACO 8, LLC (MSSP, ACO ID A3715) and Envoy Integrated Health ACO, LLC (MSSP, ACO ID A5392).

What billing organization is linked to Alan E. Skolnick, M.D.?

Alan E. Skolnick, M.D. is linked to ALASKA HEART INSTITUTE (billing NPI 1992744114) in the available physician profile data.

Does Alan E. Skolnick, M.D. have Open Payments data?

Alan E. Skolnick, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.